Abstract:ABSTRACT:This study aimed to compare between the clinical and laboratory characteristics of neurosyphilis and those of syphilis in human immunodeficiency virus (HIV) positive and explore the risk factors associated with the occurrence of neurosyphilis in the HIV infected.In-patients diagnosed with HIV and syphilis co-infection who underwent a lumbar puncture and completed cerebrospinal fluid (CSF) examination were divided into neurosyphilis group and syphilis group. The demographic characteristics, symptoms and signs, and laboratory tests of the 2 groups were comparatively analyzed. Logistic regression analysis was used to explore the risk factors associated with the occurrence of neurosyphilis.Among 81 patients, 33 patients were assigned to the neurosyphilis group, and 48 to the syphilis group. There were no significant differences in the age, gender, marital status, acquired immunodeficiency syndrome course, opportunistic infections, serum HIV viral load, and history of syphilis treatment. The difference in HIV transmission route between the 2 groups was statistically significant (P = .010), and the patients from the neurosyphilis group were mainly infected via heterosexual contact. The proportion of serum toludine red unheated serum test (TRUST) titer ≥1:16 in the neurosyphilis group were 78.8%, which was significantly higher compared to the syphilis group (48.9%). The level of CSF white blood cell count, CSF protein, and CSF HIV viral load in the neurosyphilis group were significantly higher than those of the syphilis group. The proportion of patients with neurological symptoms and signs in the neurosyphilis group was significantly higher compared to the syphilis group (P < .001). Multivariate logistic regression analysis showed that heterosexual contact transmission route, not received antiretroviral therapy, lower CD4 cell count and higher serum TRUST titer, untreated with syphilis, and neurological symptoms and signs were risk factors associated with the occurrence of neurosyphilis.The serum TRUST titer, CSF white blood cell count, CSF protein level, CSF HIV viral load, and the percentage of neurological symptoms and signs in the neurosyphilis group were higher. Heterosexual transmission route, not received antiretroviral therapy, and untreated with syphilis prompted the possibility of neurosyphilis occurrence.

Evaluation of Cerebrospinal Fluid Ubiquitin C-terminal Hydrolase-L1, Glial Fibrillary Acidic Protein, and Neurofilament Light Protein As Novel Markers for the Diagnosis of Neurosyphilis among HIV-negative Patients.

Serum Ubiquitin C-Terminal Hydrolase-L1, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain Are Good Entry Points and Biomarker Candidates for Neurosyphilis Diagnosis among Patients Without Human Immunodeficiency Virus to Avoid Lumbar Puncture

Macrophage Migration Inhibitory Factor As a Novel Cerebrospinal Fluid Marker for Neurosyphilis among HIV-negative Patients.

Assessing Cerebrospinal Fluid Abnormalities in Neurosyphilis Patients Without Human Immunodeficiency Virus Infection

Comparing Noninvasive Predictors of Neurosyphilis among Syphilis Patients with and Without HIV Co-Infection Based on the Real-World Diagnostic Criteria: A Single-Center, Retrospective Cohort Study in China.

Clinical Characteristics, Diagnosis, and Predictors of Neurosyphilis Patients with Human Immunodeficiency Virus Co-Infection

Neutrophil-associated Proteins as Novel Biomarkers Elevated in Cerebrospinal Fluid of Neurosyphilis Patients

Erratum to: Novel predictors of neurosyphilis among HIV-negative syphilis patients with neurological symptoms: an observational study

Clinical Prediction and Diagnosis of Neurosyphilis in HIV-negative Patients: a Case-Control Study

Cxcl13, Cxcl10 and Cxcl8 As Potential Biomarkers for the Diagnosis of Neurosyphilis Patients

Analysis of Treponema Pallidum DNA and CXCL13 in Cerebrospinal Fluid in HIV-Negative Syphilis Patients

Increased CCL24 and CXCL7 Levels in the Cerebrospinal Fluid of Patients with Neurosyphilis

Exosomal Microrna Profiles from Serum and Cerebrospinal Fluid in Neurosyphilis.

Large‐Scale Proteome Profiling Identifies Biomarkers Associated with Suspected Neurosyphilis Diagnosis

The clinical and laboratory features of neurosyphilis in HIV-infected patients: A retrospective study in 92 patients.

The Clinical and Laboratory Features of Neurosyphilis in HIV-infected Patients

Clinical and Laboratory Data-Based Nomograms for Neurosyphilis Diagnosis in Non-Hiv Syphilis Patients: a Cross-Sectional Study.

Circulating MicroRNAs as Potential Biomarkers in the Diagnosis of Neurosyphilis: A Case Control Study

Clinical Features of and Factors Correlated with Neurosyphilis in HIV/Syphilis Co-Infected Patients Based on Stage of Syphilis

CXCL13 Chemokine As a Promising Biomarker to Diagnose Neurosyphilis in HIV-negative Patients

Use of cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis: a three-case report